These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 3895987
1. Imipramine in the treatment of agoraphobia: dose-response relationships. Mavissakalian M, Perel J. Am J Psychiatry; 1985 Sep; 142(9):1032-6. PubMed ID: 3895987 [Abstract] [Full Text] [Related]
2. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships. Mavissakalian MR, Perel JM. Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306 [Abstract] [Full Text] [Related]
3. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings. Mavissakalian MR, Perel JM. Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933 [Abstract] [Full Text] [Related]
8. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. Mavissakalian M, Michelson L. J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534 [Abstract] [Full Text] [Related]
9. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo. Evans L, Kenardy J, Schneider P, Hoey H. Acta Psychiatr Scand; 1986 Jan; 73(1):49-53. PubMed ID: 2938422 [Abstract] [Full Text] [Related]
10. Initial depression and response to imipramine in agoraphobia. Mavissakalian M. J Nerv Ment Dis; 1987 Jun; 175(6):358-61. PubMed ID: 3295112 [Abstract] [Full Text] [Related]
11. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks. Buigues J, Vallejo J. J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985 [Abstract] [Full Text] [Related]
12. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia. Bakish D, Hooper CL, Filteau MJ, Charbonneau Y, Fraser G, West DL, Thibaudeau C, Raine D. Psychopharmacol Bull; 1996 Feb; 32(1):135-41. PubMed ID: 8927663 [Abstract] [Full Text] [Related]
13. Current drug therapy for agoraphobia. Ravaris CL. Am Fam Physician; 1981 Jan; 23(1):129-31. PubMed ID: 7457310 [Abstract] [Full Text] [Related]
14. Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. Mavissakalian M, Perel JM. Arch Gen Psychiatry; 1992 Apr; 49(4):318-23. PubMed ID: 1558466 [Abstract] [Full Text] [Related]
15. Is buspirone effective for panic disorder? Sheehan DV, Raj AB, Sheehan KH, Soto S. J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755 [Abstract] [Full Text] [Related]
16. Imipramine in agoraphobia. Mavissakalian M. Compr Psychiatry; 1986 Feb; 27(4):401-6. PubMed ID: 3731774 [No Abstract] [Full Text] [Related]
17. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia. Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R. Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824 [Abstract] [Full Text] [Related]
18. Treatment of agoraphobia with group exposure in vivo and imipramine. Zitrin CM, Klein DF, Woerner MG. Arch Gen Psychiatry; 1980 Jan; 37(1):63-72. PubMed ID: 6101535 [Abstract] [Full Text] [Related]
20. Trazodone in the treatment of panic disorder and agoraphobia with panic attacks. Mavissakalian M, Perel J, Bowler K, Dealy R. Am J Psychiatry; 1987 Jun; 144(6):785-7. PubMed ID: 3296792 [Abstract] [Full Text] [Related] Page: [Next] [New Search]